ZOM Company Profile and Key Details
AMEX : ZOM
Zomedica
$0.10
-0.0002-0.20%
At Close 4:00 PMNot Actively Trading
68.15
B+ESG ScoreESG Rating
Price Chart
Stock Price Today
Zomedica Corp. (ZOM) stock declined over -0.21%, trading at $0.10 on AMEX, down from the previous close of $0.10. The stock opened at $0.09, fluctuating between $0.09 and $0.10 in the recent session.
Stock Snapshot
0.0975
Prev. Close
95.35M
Market Cap
0.092
Day Low
-1.6216666666666666
P/E Ratio
-0.06
EPS (TTM)
-0.02
Cash Flow per Share
0.09
Open
979.95M
Number of Shares
0.0973
Day High
98.13%
Free Float in %
0.24
Book Value
790.94K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 27, 2025 | 0.05 | 0.06 | 0.05 | 0.06 | 1.36M |
| Mar 26, 2025 | 0.06 | 0.07 | 0.06 | 0.06 | 2.14M |
| Mar 25, 2025 | 0.07 | 0.07 | 0.06 | 0.06 | 1.17M |
| Mar 24, 2025 | 0.06 | 0.07 | 0.06 | 0.07 | 2.18M |
| Mar 21, 2025 | 0.08 | 0.08 | 0.05 | 0.06 | 7.91M |
| Mar 19, 2025 | 0.07 | 0.08 | 0.07 | 0.08 | 7.28M |
| Mar 17, 2025 | 0.05 | 0.07 | 0.05 | 0.07 | 15.2M |
| Mar 14, 2025 | 0.04 | 0.05 | 0.04 | 0.05 | 13.16M |
| Mar 11, 2025 | 0.03 | 0.04 | 0.03 | 0.04 | 7.35M |
| Mar 07, 2025 | 0.04 | 0.04 | 0.03 | 0.03 | 59.31M |
| Mar 06, 2025 | 0.04 | 0.05 | 0.03 | 0.04 | 31.21M |
| Mar 04, 2025 | 0.09 | 0.10 | 0.09 | 0.10 | 790.94K |
| Mar 03, 2025 | 0.11 | 0.11 | 0.10 | 0.10 | 6.04M |
| Feb 28, 2025 | 0.11 | 0.11 | 0.11 | 0.11 | 2.93M |
| Feb 27, 2025 | 0.11 | 0.11 | 0.09 | 0.10 | 7.75M |
| Feb 26, 2025 | 0.11 | 0.11 | 0.10 | 0.11 | 5.27M |
| Feb 25, 2025 | 0.12 | 0.12 | 0.11 | 0.11 | 5.76M |
| Feb 24, 2025 | 0.12 | 0.12 | 0.12 | 0.12 | 5.5M |
| Feb 21, 2025 | 0.12 | 0.12 | 0.12 | 0.12 | 3.91M |
| Feb 20, 2025 | 0.12 | 0.12 | 0.12 | 0.12 | 2.38M |
Contact Details
About Company
Zomedica Corp. is a veterinary healthcare enterprise dedicated to fulfilling the specific needs of clinical veterinarians through the creation of products for companion animals. The company is actively involved in the development and market introduction of its TRUFORMA platform, which delivers point-of-care diagnostic tools for various canine and feline illnesses. Additionally, Zomedica provides PulseVet, a system used to address a range of musculoskeletal conditions such as fractures, tendonitis, and torn ligaments in horses and smaller animals. Zomedica also maintains collaborative agreements, including one with Celsee, Inc. for the joint development and commercialization of liquid biopsy assays and consumables for detecting cancer in pets, and another with Seraph Biosciences, Inc. for the development and marketing of a novel pathogen detection system. Established in 2015 and based in Ann Arbor, Michigan, the company was formerly known as Zomedica Pharmaceuticals Corp. before adopting its current name in October 2020.
Company Information
| Employees | 144 |
| Beta | 1.16 |
| Sales or Revenue | $32.03M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Stock Peers
Technical Performance
ZOM has shown weak momentum, losing -71.13% over the past week and -76.35% over the past quarter, though year-to-date performance is down -74.83%. Short-term trend indicators are bullishly aligned (SMA20 -15.85%, SMA50 -20.38%, SMA200 -27.94%). The stock’s 14-day RSI is 22.05 (weak momentum), while the ATR of 0.0 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -50.15% below its high and over 5.76% above its low.
Dividend & Fair Value
Zomedica Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.14. This means the shares are trading below this model’s fair value.
Earnings & Analyst Outlook
Zomedica Corp. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended March 13, 2025, missed forecasts by 0.0%. The prior quarter beat by 40.06%. Over the last six quarters, Apple has recorded several small beats. These include 50.0% in February 26, 2020.
Shareholding & Insider Activity
Zomedica Corp. has 979.95 million shares outstanding. The public float is 961.65 million shares, elevated short interest at 4.63% of float. This equals 44.59 million shares. The short ratio is 6.22 days. Institutional investors hold 9.55% of the float. Insiders own 1.87%. Solensky Gerald JR holds 37.95 million shares, Klass Russell Kevin has 3.20 million shares and POWERS JOHNNY D has 2.52 million shares.
Financial & Profitability Overview
On valuation metrics, Zomedica trades at a P/E of -6.66, P/S of 2.78 and P/B of 0.86. The current ratio is 7.01 and quick ratio is 6.33. Operationally, the company’s inventory turnover is 1.97 and cash conversion cycle is 166.95 days. Debt-to-equity is 0.01, supported by a cash flow-to-debt ratio of -22.74.
Quarterly Financial Highlights
The company ended the quarter with $53.26M in cash and short-term investments, a total debt of $717.00K, and net debt of - $8.30M. Total assets were $127.04M, with equity of $115.40M. Financials further reflected weakness, with operating cash flow of - $17.65M, free cash flow of - $17.65M, and capital expenditures of $0.00.
Frequently Asked Questions
What is the current Zomedica Corp. (ZOM) stock price?
Zomedica Corp. (AMEX: ZOM) stock price is $0.10 in the last trading session. During the trading session, ZOM stock reached the peak price of $0.10 while $0.09 was the lowest point it dropped to. The percentage change in ZOM stock occurred in the recent session was -0.21% while the dollar amount for the price change in ZOM stock was - $0.00.
ZOM's industry and sector of operation?
The AMEX listed ZOM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Zomedica Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ZOM?
Mr. Evan St. Peter
Vice President of Technology Innovation
Mr. Anthony K. Blair
Chief Operating Officer
Ms. Karen DeHaan-Fullerton J.D.
Gen. Counsel, Chief Counsel & Corporation Sec.
Dr. Stephanie Laine Morley D.V.M., DVM
Consultant
Dr. William Carpenter MacArthur
Consultant
Ms. Kristin Domanski
Vice President of HR
Mr. Larry C. Heaton II
Pres, Chief Executive Officer & Director
Ms. Nicole Westfall
Vice President of Marketing
Mr. Adrian Lock
Vice President, GM & Head of Sales
Ms. Ann Marie Cotter CPA
Chief Financial Officer
Mr. Robert W. DiMarzo
Consultant
Mr. Peter L. Donato BSBA, M.B.A.
Chief Financial Officer
Mr. Greg Blair
Vice President of Bus. Devel. & Strategic Planning
Ms. Karen L. DeHaan-Fullerton J.D.
Chief Counsel & Corporation Sec.
Vice President of Technology Innovation
Mr. Anthony K. Blair
Chief Operating Officer
Ms. Karen DeHaan-Fullerton J.D.
Gen. Counsel, Chief Counsel & Corporation Sec.
Dr. Stephanie Laine Morley D.V.M., DVM
Consultant
Dr. William Carpenter MacArthur
Consultant
Ms. Kristin Domanski
Vice President of HR
Mr. Larry C. Heaton II
Pres, Chief Executive Officer & Director
Ms. Nicole Westfall
Vice President of Marketing
Mr. Adrian Lock
Vice President, GM & Head of Sales
Ms. Ann Marie Cotter CPA
Chief Financial Officer
Mr. Robert W. DiMarzo
Consultant
Mr. Peter L. Donato BSBA, M.B.A.
Chief Financial Officer
Mr. Greg Blair
Vice President of Bus. Devel. & Strategic Planning
Ms. Karen L. DeHaan-Fullerton J.D.
Chief Counsel & Corporation Sec.
How ZOM did perform over past 52-week?
ZOM's closing price is 544.37% higher than its 52-week low of $0.02 where as its distance from 52-week high of $0.20 is -50.15%.
How many employees does ZOM have?
Number of ZOM employees currently stands at 144.
Link for ZOM official website?
Official Website of ZOM is: https://www.zomedica.com
How do I contact ZOM?
ZOM could be contacted at phone 734 369 2555 and can also be accessed through its website. ZOM operates from 100 Phoenix Drive, Ann Arbor, MI 48108, United States.
How many shares of ZOM are traded daily?
ZOM stock volume for the day was 790.94K shares. The average number of ZOM shares traded daily for last 3 months was 8.54M.
What is the market cap of ZOM currently?
The market value of ZOM currently stands at $95.35M with its latest stock price at $0.10 and 979.95M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep